-
New Forum Software Installed (Still a few issues but reopening the forum) More details.
solriamfetol
-
Preprint Solriamfetol improves daily fatigue symptoms in adults with [ME/CFS] after eight weeks of treatment, 2025, Young et al
Abstract: Background: Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a long-term illness with no treatment options that address the disease directly. Solriamfetol is a selective dual norepinephrine-dopamine reuptake inhibitor that promotes wakefulness in obstructive sleep apnea...- Nightsong
- Thread
- joel young solriamfetol
- Replies: 18
- Forum: ME/CFS research
-
Open A Trial of Solriamfetol in the Treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, Joel L Young, 2020
https://www.clinicaltrials.gov/ct2/show/NCT04622293 https://thejewishnews.com/2020/10/07/new-hope-for-chronic-fatigue-sufferers/- John Mac
- Thread
- adhd dopamine joel young norepinephrine solriamfetol sunosi treatment
- Replies: 9
- Forum: Recruitment into current ME/CFS research studies